Share

July 2020; 7 (4) CORRECTION

Neurologic syndromes related to anti-GAD65: Clinical and serologic response to treatment

First published April 15, 2020, DOI: https://doi.org/10.1212/NXI.0000000000000733
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
339

Share

See original article:

Article Information

vol. 7 no. 4 e733
DOI: 
https://doi.org/10.1212/NXI.0000000000000733
PubMed: 
32295823
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Online ISSN: 
2332-7812
History: 
  • First Published April 15, 2020.
Copyright & Usage: 
© 2020 American Academy of Neurology

Author Disclosures

    View Full Text

    Article usage

    Article usage: April 2020 to May 2022

    AbstractFullPdfSource
    Apr 2020618770Highwire
    May 2020010552Highwire
    Jun 20201539Highwire
    Jul 2020212526Highwire
    Aug 202005013Highwire
    Sep 2020118912Highwire
    Oct 202024813Highwire
    Nov 202022713Highwire
    Dec 20202242Highwire
    Jan 20212268Highwire
    Feb 20213296Highwire
    Mar 20210308Highwire
    Apr 20212246Highwire
    May 20210233Highwire
    Jun 20210243Highwire
    Jul 20211246Highwire
    Aug 20210235Highwire
    Sep 20211246Highwire
    Oct 202101913Highwire
    Nov 202102217Highwire
    Dec 20210247Highwire
    Jan 20220428Highwire
    Feb 20221316Highwire
    Mar 20220388Highwire
    Apr 20220303Highwire
    May 202203616Highwire

    Letters: Rapid online correspondence

    No comments have been published for this article.
    Comment

    REQUIREMENTS

    If you are uploading a letter concerning an article:
    You must have updated your disclosures within six months: http://submit.neurology.org

    Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

    If you are responding to a comment that was written about an article you originally authored:
    You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
    and apply to letter.

    Submission specifications:

    • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
    • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
    • Submit only on articles published within 6 months of issue date.
    • Do not be redundant. Read any comments already posted on the article prior to submission.
    • Submitted comments are subject to editing and editor review prior to posting.

    More guidelines and information on Disputes & Debates

    Compose Comment

    More information about text formats

    Plain text

    • No HTML tags allowed.
    • Web page addresses and e-mail addresses turn into links automatically.
    • Lines and paragraphs break automatically.
    Author Information
    NOTE: The first author must also be the corresponding author of the comment.
    First or given name, e.g. 'Peter'.
    Your last, or family, name, e.g. 'MacMoody'.
    Your email address, e.g. higgs-boson@gmail.com
    Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
    Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
    Publishing Agreement
    NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

    Vertical Tabs

    You May Also be Interested in

    Back to top

    Related Articles

    Alert Me

    Advertisement